Care for head and neck cancer increasingly regionalized
(HealthDay)—Care for head and neck cancer is becoming increasingly regionalized, according to research published online Sept. 5 in JAMA Otolaryngology-Head & Neck Surgery.
Sep 7, 2013
0
0
(HealthDay)—Care for head and neck cancer is becoming increasingly regionalized, according to research published online Sept. 5 in JAMA Otolaryngology-Head & Neck Surgery.
Sep 7, 2013
0
0
Johns Hopkins scientists have identified a molecular marker called "Mig 6" that appears to accurately predict longer survival—up to two years—among patients prescribed two of the most widely used drugs in a class of anticancer ...
Sep 5, 2013
0
0
A study at UCLA's Jonsson Comprehensive Cancer Center has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to need a feeding tube or suffer unwanted side effects such ...
Sep 4, 2013
0
1
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome (OSAHS).
Aug 27, 2013
2
0
(HealthDay)—For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.
Aug 16, 2013
0
0
Scientists have long been worried about the possible harmful effects of regular cellular phone use, but so far no study has managed to produce clear results. Currently, cell phones are classified as carcinogenic category ...
Jul 29, 2013
0
0
A study led by researchers at The Ohio State University Comprehensive Cancer Center-– Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) has identified a biochemical pathway in cancer ...
Jun 18, 2013
0
0
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher ...
Jun 2, 2013
0
0
Scientists at the University of Leeds have found a way to target and destroy a key protein associated with the development of cervical and other cancers.
May 30, 2013
0
0
A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...
May 20, 2013
0
0